Loading...
XSHG
605186
, Last price  
Name

Shanghai General Healthy Information and Technology Co Ltd

Chart & performance

D1W1MN
XSHG:605186 chart
P/E
—
P/S
—
EPS
0.23
Vol. 1Y
—
Shs. 5Y
5.61%
Rev. 5Y
3.79%
Div Yld LY
—
Div Yld TTM
—
Revenues
345m
+8.52%
205,079,789233,048,589256,457,603300,239,668286,806,988489,755,358322,359,785307,559,137318,349,489345,486,037
Net income
31m
-5.34%
17,588,72555,401,75274,636,35491,902,52495,739,271117,618,143115,681,54459,999,96432,520,68130,782,546
CFO
97m
+447.16%
58,224,70057,011,45367,927,55876,034,54071,777,50853,827,7550-35,393,79217,677,55496,724,014
Dividend
Aug 23, 20240.1 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai General Healthy Information and Technology Co., Ltd. (SGHIT) delivers a range of advanced solutions to the healthcare sector in China. These encompass automated pharmaceutical logistics, cutting-edge information technology, and intelligent, mobile medical applications. Its core product portfolio features the "Smart Pharmacy Project," an integrated hardware and software system designed for intelligent medication management. Another key offering is the "Intelligent Static Distribution Center Project," a sophisticated system for the configuration and oversight of intravenous medications. Additionally, the "Intelligent Drug Consumables Management Project" provides specialized oversight for various pharmaceutical supplies, including controlled substances and high-value medical items. Established in 2014, SGHIT operates from its headquarters in Shanghai, China.
IPO date
Dec 22, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT